Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
03/07/2014 | 16:14 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22:46 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
25/06/2014 | 22:12 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
24/06/2014 | 12:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22:48 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22:35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/06/2014 | 22:13 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
19/06/2014 | 22:30 | GlobeNewswire Inc. | NORTHERA(TM) Clinical Trial Data Published in Neurology | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
12/06/2014 | 13:30 | GlobeNewswire Inc. | Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Move... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
06/06/2014 | 13:00 | GlobeNewswire Inc. | Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
02/06/2014 | 21:32 | PR Newswire (US) | The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
28/05/2014 | 21:26 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/05/2014 | 22:54 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
23/05/2014 | 22:16 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
21/05/2014 | 16:58 | Business Wire | Chelsea Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate the Acquisition Pr... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
12/05/2014 | 17:44 | PR Newswire (US) | Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
12/05/2014 | 15:05 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
10/05/2014 | 03:15 | Business Wire | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
10/05/2014 | 02:40 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
10/05/2014 | 01:51 | PR Newswire (US) | Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancor... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 22:49 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 16:35 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 16:08 | Business Wire | Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd. | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 15:11 | PR Newswire (US) | Law Offices of Marc S. Henzel Announces Securities Class Action Periods | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 03:00 | Business Wire | SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with th... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
09/05/2014 | 00:35 | Business Wire | Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
08/05/2014 | 23:25 | PR Newswire (US) | SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
08/05/2014 | 23:12 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
08/05/2014 | 23:09 | PR Newswire (US) | INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Di... | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |
08/05/2014 | 19:21 | Business Wire | CHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:CHTP | Chelsea Therapeutics International, Ltd. (MM) |